Search Results - "HRUBY, V. J"

Refine Results
  1. 1

    Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential by Sandweiss, A J, McIntosh, M I, Moutal, A, Davidson-Knapp, R, Hu, J, Giri, A K, Yamamoto, T, Hruby, V J, Khanna, R, Largent-Milnes, T M, Vanderah, T W

    Published in Molecular psychiatry (01-08-2018)
    “…Development of an efficacious, non-addicting analgesic has been challenging. Discovery of novel mechanisms underlying addiction may present a solution. Here we…”
    Get full text
    Journal Article
  2. 2

    Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance by Largent‐Milnes, TM, Yamamoto, T, Nair, P, Moulton, JW, Hruby, VJ, Lai, J, Porreca, F, Vanderah, TW

    Published in British journal of pharmacology (01-11-2010)
    “…BACKGROUND AND PURPOSE The use of opioids in treating pain is limited due to significant side effects including somnolence, constipation, analgesic tolerance,…”
    Get full text
    Journal Article
  3. 3

    Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads by Hruby, V J, Balse, P M

    Published in Current medicinal chemistry (01-09-2000)
    “…The design of peptidomimetic ligands with agonist biological activities in vitro and in vivo has been challenging. Lofty goals have been set for this research…”
    Get more information
    Journal Article
  4. 4

    Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands by Bird, M.F., Vardanyan, R.S., Hruby, V.J., Calò, G., Guerrini, R., Salvadori, S., Trapella, C., McDonald, J., Rowbotham, D.J., Lambert, D.G.

    Published in British journal of anaesthesia : BJA (01-04-2015)
    “…Opioid tolerance is a limiting factor in chronic pain. Delta opioid peptide (DOP)(δ) receptor antagonism has been shown to reduce tolerance. Here, the common…”
    Get full text
    Journal Article
  5. 5

    Design in Topographical Space of Peptide and Peptidomimetic Ligands That Affect Behavior. A Chemist's Glimpse at the Mind−Body Problem by Hruby, Victor J

    Published in Accounts of chemical research (01-05-2001)
    “…Efforts to determine the bioactive conformations of peptide ligands for membrane-bound proteins such as G-protein-coupled receptors (GPCRs) have been…”
    Get full text
    Journal Article
  6. 6

    Exploring Ramachandran and chi space: conformationally constrained amino acids and peptides in the design of bioactive polypeptide ligands by Cowell, S M, Lee, Y S, Cain, J P, Hruby, V J

    Published in Current medicinal chemistry (01-11-2004)
    “…Ligand binding and concomitant changes in receptor structure provide the means to target signal transduction pathways. With appropriate refinement of the…”
    Get more information
    Journal Article
  7. 7

    Role of melanocortinergic neurons in feeding and the agouti obesity syndrome by Fan, W, Boston, B.A, Kesterson, R.A, Hruby, V.J, Cone, R.D

    Published in Nature (London) (09-01-1997)
    “…Dominant alleles at the agouti locus (A) cause an obesity syndrome in the mouse, as a consequence of ectopic expression of the agouti peptide. This peptide,…”
    Get full text
    Journal Article
  8. 8

    Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors by WESSELLS, H, HRUBY, V. J, HACKETT, J, HAN, G, BALSE-SRINIVASAN, P, VANDERAH, T. W

    Published in Neuroscience (01-01-2003)
    “…Penile erection induced by alpha-melanocyte-stimulating hormone and melanocortin receptors (MC-R) in areas of the spinal cord and periphery has not been…”
    Get full text
    Journal Article
  9. 9

    D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity by Grieco, P, Balse, P M, Weinberg, D, MacNeil, T, Hruby, V J

    Published in Journal of medicinal chemistry (28-12-2000)
    “…In our search for potent and receptor-selective agonists and antagonists, we report here the results of D-amino acid substitution at each position of the short…”
    Get full text
    Journal Article
  10. 10

    Solid-Phase Synthesis of O-Linked Glycopeptide Analogues of Enkephalin by Mitchell, Scott A, Pratt, Matt R, Hruby, Victor J, Polt, Robin

    Published in Journal of organic chemistry (06-04-2001)
    “…The synthesis of 18 N-α-FMOC-amino acid glycosides for solid-phase glycopeptide assembly is reported. The glycosides were synthesized either from the…”
    Get full text
    Journal Article
  11. 11

    SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist by Bilsky, E J, Calderon, S N, Wang, T, Bernstein, R N, Davis, P, Hruby, V J, McNutt, R W, Rothman, R B, Rice, K C, Porreca, F

    “…The present study has investigated the pharmacology of SNC 80, a nonpeptidic ligand proposed to be a selective delta agonist in vitro and in vivo. SNC 80 was…”
    Get more information
    Journal Article
  12. 12

    Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions by Salamon, Z, Cowell, S, Varga, E, Yamamura, H I, Hruby, V J, Tollin, G

    Published in Biophysical journal (01-11-2000)
    “…Structural changes accompanying the binding of ligands to the cloned human delta-opioid receptor immobilized in a solid-supported lipid bilayer have been…”
    Get full text
    Journal Article
  13. 13

    Design of Novel Chimeric Melanotropin−Deltorphin Analogues. Discovery of the First Potent Human Melanocortin 1 Receptor Antagonist by Han, G, Quillan, J. M, Carlson, K, Sadée, W, Hruby, V. J

    Published in Journal of medicinal chemistry (27-02-2003)
    “…A number of novel α-melanotropin (α-MSH) analogues have been designed, synthesized, and assayed for bioactivity at the melanocortin-1 (MC1) receptor from…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    A new type of synthetic peptide library for identifying ligand-binding activity by Lam, Kit S, Salmon, Sydney E, Hersh, Evan M, Hruby, Victor J, Kazmierski, Wieslaw M, Knapp, Richard J

    Published in Nature (London) (07-11-1991)
    “…Our aim was to improve techniques for drug development by facilitating the identification of small molecules that bind with high affinity to acceptor molecules…”
    Get full text
    Journal Article
  17. 17

    Enkephalin Glycopeptide Analogues Produce Analgesia with Reduced Dependence Liability by Bilsky, Edward J, Egleton, Richard D, Mitchell, Scott A, Palian, Michael M, Davis, Peg, Huber, Jason D, Jones, Heather, Yamamura, Henry I, Janders, Jacqueline, Davis, Thomas P, Porreca, Frank, Hruby, Victor J, Polt, Robin

    Published in Journal of medicinal chemistry (29-06-2000)
    “…Endogenous peptides (e.g. enkephalins) control many aspects of brain function, cognition, and perception. The use of these neuroactive peptides in diverse…”
    Get full text
    Journal Article
  18. 18

    Molecular biology and pharmacology of cloned opioid receptors by Knapp, R J, Malatynska, E, Collins, N, Fang, L, Wang, J Y, Hruby, V J, Roeske, W R, Yamamura, H I

    Published in The FASEB journal (01-04-1995)
    “…The cloning and expression of DNA for the three major opioid receptor types (mu, delta, and kappa) present new research opportunities for the characterization…”
    Get more information
    Journal Article
  19. 19

    Plasmon resonance methods in GPCR signaling and other membrane events by Alves, I D, Park, C K, Hruby, V J

    Published in Current protein & peptide science (01-08-2005)
    “…The existence of surface guided electromagnetic waves has been theoretically predicted from Maxwell's equations and investigated during the first decades of…”
    Get more information
    Journal Article
  20. 20

    The effect of halogenation on blood–brain barrier permeability of a novel peptide drug by Gentry, C.L, Egleton, R.D, Gillespie, T, Abbruscato, T.J, Bechowski, H.B, Hruby, V.J, Davis, T.P

    Published in Peptides (New York, N.Y. : 1980) (01-10-1999)
    “…The utility of a drug depends on its ability to reach appropriate receptors at the target tissue and remain metabolically stable to produce the desired effect…”
    Get full text
    Journal Article